Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

GTBP holding history

GT Biopharma, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GTBP overviewAll 13F holders of GTBPFull Q4 2025 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of GTBP by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−10,504−100.0%Sold outHolders
Q3 202510,504$6.25K<0.1%00.0%UnchangedHolders
Q2 202510,504$37.6K<0.1%00.0%UnchangedHolders
Q1 202510,504$23.5K<0.1%00.0%UnchangedHolders
Q4 202410,504$32.0K<0.1%00.0%UnchangedHolders
Q3 202410,504$24.1K<0.1%00.0%UnchangedHolders
Q2 202410,504$29.7K<0.1%−10,008−48.8%ReducedHolders
Q1 202420,512$90.9K<0.1%−15,754−43.4%ReducedConverted for a 1-for-30 splitHolders
Q4 20231,087,993$277.4K<0.1%+759+0.1%AddedHolders
Q3 20231,087,234$262.1K<0.1%−12,120−1.1%ReducedHolders
Q2 20231,099,354$343.0K<0.1%−28,051−2.5%ReducedHolders
Q1 20231,127,405$620.1K<0.1%00.0%UnchangedHolders
Q4 20221,127,405$998.5K<0.1%+4640.0%AddedHolders
Q3 20221,126,941$1.98M<0.1%+1000.0%AddedHolders
Q2 20221,126,841$3.37M<0.1%+138,899+14.1%AddedHolders
Q1 2022987,942$2.85M<0.1%−218,410−18.1%ReducedHolders
Q4 20211,206,352$3.68M<0.1%+243,029+25.2%AddedHolders
Q3 2021963,323$6.49M<0.1%−18,946−1.9%ReducedHolders
Q2 2021982,269$15.2M<0.1%+714,605+267.0%AddedHolders
Q1 2021267,664$1.83M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.